Dr Lisa Lindquist, Senior Postdoctoral Fellow
Walter and Eliza Hal
Institute, Division of Cell Signalling
and Cell Death
Autophagy or “self-eating”
is a vital catabolic process that recycles bulk cytoplasmic material but can
also selectively degrade organelles such as mitochondria. While autophagy
reduces autoimmune and inflammatory responses, aberrant autophagy is linked to
cancer and neurological diseases. For the last 10 years there has been an
enduring dogma that the pro-survival Bcl-2 family members inhibit autophagy by
directly binding to the autophagy protein Beclin 1. However, Lisa’s work
overturned this model by revealing that the pro-survival Bcl-2 family members
absolutely require Bax and Bak, the effectors of intrinsic apoptosis, to
regulate autophagy. She is currently investigating how these early stages of
cell suicide initiate autophagy, which occurs independently of caspase
activation and cell death.
Lisa specialises at tackling
questions at the interface of fields, such as between protein synthesis and apoptosis,
and apoptosis and autophagy. Her research is largely focused on drug
development for cancer therapy and characterizing the physiological effects of
those inhibitors. She received her PhD from McGill University (Canada) and is
currently a postdoctoral fellow in the Cell Signalling and Cell division.
Research gate profile: https://www.researchgate.net/profile/Lisa_Lindqvist/info
Please contact andrea.johannessen@monash.edu
to schedule a meeting with Lisa after the seminar.
A light lunch is served prior to the seminar at
11:45am in the seminar room foyer, level 2, TRF Building.Further information, including the link to add the seminar series to your google calendar, is available from CID Weekly Seminar Series website [http://www.med.monash.edu.au/scs/medicine/cid/seminar-series.html]
No comments:
Post a Comment